share_log

CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

cbdmd推出药草绿洲社交饮料,源自大麻的THC气泡水
newsfile ·  11/15 03:26

Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie, hemp derived THC seltzer line designed to elevate social occasions with a blend of premium cannabinoids and adaptogenic mushrooms. Available in four delicious flavors—Lemon Lift, Tropical Twist, Mango Bliss, and Berry Fusion—Herbal Oasis is designed to deliver an experience that enhances social connection and well-being, offering an alternative to traditional alcoholic drinks.

北卡罗来纳州夏洛特--(新闻档案公司 - 2024 年 11 月 14 日)- cbdMD, Inc.(纽交所美国:YCBD)(纽交所美国:YCBD-PA),作为全球公认的健康与大麻素行业领导者,兴奋地宣布推出草本绿洲社交饮品——一款精心制作的低热量、从大麻中提取的THC气泡水,旨在通过优质大麻素和适应性真菌的混合提升社交场合。草本绿洲提供四种美味口味——柠檬提神、热带旋风、芒果快乐和浆果融合——旨在提供一种增强社交联系和幸福感的体验,提供传统酒精饮料的替代品。

As the first entry of its kind for cbdMD, the Company believes Herbal Oasis is set to redefine what social drinking can look like in a wellness-centered lifestyle. Each can features a thoughtfully balanced formula: 5mg of hemp derived THC and 5mg of CBG, complemented by a nootropic blend of functional ingredients like Lion's Mane, Reishi, Maitake, and Cordyceps mushrooms along with L-theanine and B12. With a focus on enhancing social experiences, this blend is crafted to provide calm, clarity, and energy, helping consumers feel engaged, vibrant, and connected in any social setting.

作为cbdMD的首个此类产品,公司相信草本绿洲将重新定义健康生活方式中的社交饮酒。每罐饮品都具有经过深思熟虑的平衡配方:5毫克的大麻提取THC和5毫克的CBG,配合如狮子鬃、灵芝、舞茸和虫草等功能成分的提神保健混合物,以及L-茶氨酸和B12。专注于增强社交体验,这一配方旨在提供平静、清晰和能量,帮助消费者在任何社交场合中感到投入、充满活力和联系。

Herbal Oasis Social Tonics

草本绿洲社交饮品

Microencapsulated & Fast-Acting Social Tonic for the Sober-Curious and Beyond

为清醒探寻者及其他人提供的微胶囊化和快速生效的社交饮品

The product has been in development for nearly a year, designed to have superior taste and a balanced formulation that aligns with current trends for an alcohol-free lifestyle. Incorporating a nano-liposomal technology for faster absorption, Herbal Oasis Social Tonics offers fast-acting effects. Consumers should begin to feel the effects within approximately 10-15 minutes after consumption.

该产品的开发历时近一年,旨在提供优越的口感和与当前无酒精生活方式趋势相一致的平衡配方。采用纳米脂质体技术以实现更快的吸收,草本绿洲社交饮品提供快速生效的效果。消费者在消费后约 10-15 分钟内应开始感受到效果。

"We are thrilled to introduce Herbal Oasis as part of the emerging hemp-derived delta 9 category," said Ronan Kennedy, CEO of cbdMD. "With Herbal Oasis, we wanted to bring together the finest aspects of ancient wellness traditions and modern innovation, delivering an alcohol-free alternative for social connection and mindful engagement. It's an experience that our consumers can feel good about, one that aligns with their wellness-focused lifestyles."

“我们很高兴将草本绿洲作为新兴的大麻提取的delta 9类别的一部分介绍,”cbdMD首席执行官Ronan Kennedy说。“通过草本绿洲,我们希望结合古老健康传统和现代创新的最佳方面,提供一种无酒精的社交联系和专注参与的替代品。这是一种我们的消费者可以为之感到自豪的体验,与他们以健康为中心的生活方式相一致。”

The Fastest-Growing Segment in an Emerging Industry

新兴行业中增长最快的细分市场

As the THC and CBD beverage markets continue to expand, the social tonics category is emerging as the fastest-growing segment in the industry. The "sober-curious" movement and an increasing focus on wellness have fueled a demand for healthier, non-alcoholic alternatives that promote well-being. According to recent Euromonitor International estimates, the adult hemp beverage market totaled approximately $230 million in 2023, will triple in 2024, and is on its way to over $4 billion by 2028 as consumers seek new, mindful ways to enjoy their social lives without consuming alcohol.

随着THC和CBD饮料市场的持续扩展,社交饮料类别正在成为行业中增长最快的细分市场。 "清醒好奇"运动以及对健康的日益关注推动了对有益健康的非酒精替代品的需求,这些替代品促进了身心健康。根据最近的Euromonitor International估计,2023年成年大麻饮料市场总额约为23000万,到2024年将增长三倍,并将在2028年突破40亿,因为消费者寻求新的、有意识的方式享受社交生活而不需要饮用酒精。

cbdMD's move into this rapidly expanding space underscores the brand's commitment to innovation and addressing consumer trends head-on. By offering Herbal Oasis, cbdMD provides a sophisticated, wellness-driven option that will be marketed to a range of adult consumers, from "Life of the Party" personalities looking for a healthier social buzz, to wellness enthusiasts and sober-curious individuals seeking clarity and connection.

cbdMD进军这一快速扩展领域,突显了品牌对创新的承诺,并积极应对消费趋势。通过提供Herbal Oasis,cbdMD为成年消费者提供了一种精致、注重健康的选择,面向"派对之王"等寻求更健康社交体验的人士,以及关注健康和清醒好奇的人士,寻找清晰和连接。

Availability

了解有关VAST与思科和NVIDIA的进一步合作,请单击此处:

Herbal Oasis Social Tonics are currently available at cbdMD.com and in select markets in North Carolina and Alabama, with plans for broader distribution in the coming months. Through cbdMD's nationwide1 shipping, adult consumers across the U.S. can conveniently order Herbal Oasis products and have them delivered discreetly to their front door, allowing everyone to discover the refreshing, wellness-focused experience of Herbal Oasis from the comfort of home. For more information about Herbal Oasis Social Tonics or to stay updated on product availability, please visit cbdMD.com or contact our customer support team.

Herbal Oasis社交饮料目前在cbdMD.com以及北卡罗来纳州和阿拉巴马州的部分市场提供,并计划在未来几个月内扩大分销。通过cbdMD的全国性配送,来自美国的成年消费者可以方便地订购Herbal Oasis产品,并将其配送到家门口,让每个人都能在舒适的家中体验Herbal Oasis所提供的清新、注重健康的体验。有关Herbal Oasis社交饮料的更多信息或获取产品可用性的最新信息,请访问cbdMD.com或联系我们的客户支持团队。

About cbdMD

关于cbdMD,cbdMD,Inc.是美国领先的、最值得信赖和最被认可的大麻二酚(CBD)品牌之一,拥有全面的美国生产、无THC CBD产品系列,包括NSF体育认证产品以及各种全光谱产品。我们的cbdMD品牌目前包括高级别的、优质的CBD产品,包括CBD口服液、CBD软糖、CBD外用疗法、CBD胶囊、CBD助眠剂以及不断增长的Farm Act合规性Delta 9产品系列。我们的Paw CBD宠物产品品牌包括兽医配制的产品,包括具有不同强度的口服液和牛肉干,我们的ATRx Labs品牌是一种天然的功能蘑菇支持。要了解有关cbdMD的更多信息以及我们的全面的美国种植、无THC的CBD油和全光谱产品以及我们的其他品牌,请访问 、 ,或ATRxLabs.com,关注cbdMD的Instagram和Facebook或访问全国数千家零售商中的一家,以了解cbdMD的产品。

cbdMD is a premium, consumer-centric wellness company focused on bringing innovation and quality to the cannabinoid industry with a comprehensive line of U.S. produced, THC-free2 CBD products, including NSF Certified for Sport products, as well as a wide array of Full Spectrum products. Our cbdMD brand currently includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids, and a growing collection of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products including tinctures and chews in varying strengths, and our ATRx Labs brand of natural functional mushroom support. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD oil and Full Spectrum products as well as our other brands, please visit , , or ATRxLabs.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retailers nationwide that carry cbdMD's products.

cbdMD是一家以消费者为中心的高端健康公司,专注于为大麻行业带来创新和质量,提供一系列美国生产的无THC2 CBD产品,包括NSF认证的运动产品,以及多种全谱产品。我们的cbdMD品牌目前涵盖高品质、优质的CBD产品,包括CBD酊剂、CBD软糖、CBD外用药物、CBD胶囊、CBD助眠剂和不断增长的符合农业法案的Delta 9产品。我们的Paw CBD宠物产品品牌包含兽医配方的产品,包括不同强度的酊剂和咀嚼片,以及我们的ATRx Labs自然功能性蘑菇支持品牌。要了解有关cbdMD以及我们全面的美国种植、无THC1 CBD油和全谱产品及其他品牌的更多信息,请访问、或ATRxLabs.com,关注cbdMD的Instagram和Facebook,或访问全国数千家销售cbdMD产品的零售商之一。

Forward-Looking Statements

前瞻性声明

This communication contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including with regard to market acceptance of new products, availability of new products and potential regulation of new produces. These forward-looking statements are based on management's beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to those described in our Form 10-K and other filings with the U.S. Securities and Exchange Commission. All information set forth in this press release is as of the date hereof. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.

This communication contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including with regard to market acceptance of new products, availability of new products and potential regulation of new produces. These forward-looking statements are based on management's beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to those described in our Form 10-k and other filings with the U.S. Securities and Exchange Commission. All information set forth in this press release is as of the date hereof. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.

1 As permitted by local jurisdiction.

1 As permitted by local jurisdiction.

2THC-free is defined as below the level of detection using validated scientific analytical methods.

2THC-free is defined as below the level of detection using validated scientific analytical methods.

Contact Information:

联系方式:

cbdMD, Inc.
Ronan Kennedy, CEO & CFO
+1 (704) 445-3064
IR@cbdmd.com

cbdMD, Inc.
Ronan Kennedy, CEO & CFO
+1 (704) 445-3064
IR@cbdmd.com

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发